The Myeloproliferative Disorders Drugs Global Market Report 2023, provides comprehensive information on the myeloproliferative disorders drugs market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Myeloproliferative Disorders Drugs Market’s Growth:
The global myeloproliferative disorders drugs market size is expected to grow from $8.63 billion in 2022 to $9.11 billion in 2023 at a compound annual growth rate (CAGR) of 5.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global myeloproliferative disorders drugs market size is expected to reach $10.62 billion in 2027 at a CAGR of 3.9%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=10681&type=smp
Product innovation has emerged as a key trend gaining popularity in the myeloproliferative disorder drugs market. Major companies operating in myeloproliferative disorder market are concentrating their efforts on creating innovative products to strengthen their position in the market. For instance, in April 2020, Bristol Myers Squibb, a US-based biopharmaceutical company, received approval for REBLOZYL (luspatercept-aamt) by the US Food and Drug Administration for the treatment of anemia in adult patients with very low- to intermediate-risk myelodysplastic syndromes with ring side oblasts (MDS-RS) or myeloproliferative neoplasms with ring side oblasts and thrombocytosis (MDS/MPN-RS-T). It is an injection-only prescription medication used to treat anemia in patients who require frequent red blood cell transfusions and have not reacted well to, or are unable to take, other types of medication.
The myeloproliferative disorders drugs market is segmented:
1) By Type: Primary Myelofibrosis, Polycythemia Vera (PV), Essential Thrombocythemia (ET), Chronic Eosinophilic Leukemia Or Hyper eosinophilic Syndrome (HES), Systemic Masto cytosis (SM)
2) By Drug Type: JAK2 Inhibitors, Anti-Neoplastics, Demethylation Agents, Imatinib Mesylate, Other Drug Types
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Stores, Drug Stores
North America was the largest region in the myeloproliferative disorders drugs market in 2022.
The table of contents in TBRC’s myeloproliferative disorders drugs market report includes:
- Executive Summary
- Myeloproliferative Disorders Drugs Market Characteristics
- Myeloproliferative Disorders Drugs Market Trends And Strategies
- Myeloproliferative Disorders Drugs Market – Macro Economic Scenario
- Myeloproliferative Disorders Drugs Market Size And Growth
.
.
.
- Middle East Myeloproliferative Disorders Drugs Market
- Africa Myeloproliferative Disorders Drugs Market
- Myeloproliferative Disorders Drugs Market Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions In The Myeloproliferative Disorders Drugs Market
- Myeloproliferative Disorders Drugs Market Future Outlook and Potential Analysis
Top Major Players
- Novartis AG
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
